<![CDATA[Corona virus diseases-19 (COVID-19) affects the respiratory system and the kidneys. Kidney disorders manifestations in COVID-19 patients are AKI, AKI superimposed chronic kidney disease (CKD), and COVID -19 in CKD sufferers on hemodialysis. The SARS CoV-2 virus can cause deterioration and decline in kidney function because it can bond with angiotensin converting enzyme 2 (ACE-2) receptors on the surface cells of the kidney. This study is a descriptive cross-sectional study that aims to know the profile of kidney abnormalities in COVID -19 patients treated at Dustira Hospital based on the description of age, sex, type of kidney disorder, therapy, and outcome of therapy. This study takes the total sampling data in the form of medical record data from January to December 2021. During this time 275 samples were obtained. Research results show the average age of patients is 57 + 13.5 years. The majority of the patients were male (58.5%). The highest percentage of diagnosed kidney disorders in COVID-19 patients was AKI-superimposed CKD (38.2%). 53.5% COVID-19 patients with kidney disorders received conservative therapy, while 46.5% received hemodialysis With 68.7% conservative therapy and 77.3% hemodialysis, the majority of Covid-19 patients with kidney disorders were able to survive. The study concludes that COVID-19 with kidney disorders is most common in elderly men (>55 years), with the most cases developing AKI-superimposed CKD. There were a lot of patients who receive conservative therapy but endure life, and many have therapy action hemodialysis, resulting in a higher survival rate.]]>
Copyrights © 2023
